2023
DOI: 10.1016/j.drudis.2022.103439
|View full text |Cite
|
Sign up to set email alerts
|

Docking-based generative approaches in the search for new drug candidates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
20
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(20 citation statements)
references
References 58 publications
0
20
0
Order By: Relevance
“…These models are essentially ligand-based, as they rely on the prior knowledge of known actives to design similar molecules that potentially bind to the same target with the possibility to fine-tune their physicochemical properties 16,17 . To evaluate how well the new molecules bind to the target protein and prioritize them for synthesis, they can be followed up with subsequent structure-based docking calculations or molecular dynamics (MD) simulations 18 . The separation of molecular generation and structure-based evaluation, however, will render the whole process inefficient and severely limits the utility of molecular generative models in practical drug discovery projects.…”
Section: Introductionmentioning
confidence: 99%
“…These models are essentially ligand-based, as they rely on the prior knowledge of known actives to design similar molecules that potentially bind to the same target with the possibility to fine-tune their physicochemical properties 16,17 . To evaluate how well the new molecules bind to the target protein and prioritize them for synthesis, they can be followed up with subsequent structure-based docking calculations or molecular dynamics (MD) simulations 18 . The separation of molecular generation and structure-based evaluation, however, will render the whole process inefficient and severely limits the utility of molecular generative models in practical drug discovery projects.…”
Section: Introductionmentioning
confidence: 99%
“…[15,16] Molecular docking and dynamics are powerful approaches for understanding the structural interactions between binding molecules and protein targets, predicting the optimal binding form. [17,18] Furthermore, absorption, distribution, metabolism, excretion, and toxicity (ADME/Tox) analysis can be used to evaluate the bioavailability and toxicity profile of molecules. [19,20] In this present study, we employed Gaussian field-based 3D-QSAR and atom-based 3D-QSAR with the PHASE module (2021 version, Schrödinger, LLC, NY) to analyze a series of triazole derivatives with cytotoxic activities.…”
Section: Introductionmentioning
confidence: 99%
“…Screening of virtual libraries of synthesizable compounds has become an increasingly important step in drug discovery 1 . The surge in utilization of computational approaches has been stimulated by improvements in binding energy calculations, the growth of computational resources, advances in protein structures determination and availability of large and diverse virtual libraries of compounds [2][3][4][5][6][7][8][9] . However, our ability to access the vast druggable chemical space is still limited and will be impacted by the availability of sufficient computing resources for the foreseeable future 10,11 .…”
Section: Introductionmentioning
confidence: 99%